nasal delivery

Latest Headlines

Latest Headlines

Nasal version of naloxone for opioid overdose gets on FDA's fast track

The first nasally administered naloxone-based therapy to treat emergency cases of opioid overdose from heroin or prescription painkillers received a Fast Track Designation from the FDA, product developer AntiOp said in a July 15 statement.

FDA approves first nasally delivered gel for 'Low T'

FDA's May 28 approval of Natesto, the first nasally delivered testosterone gel for hypogonadism, came just in time for Canada's Trimel Pharmaceuticals, which had just $18 million left on hand at the beginning of the year.

Reckitt Benckiser to develop nasal spray for emergency overdose of opioids

Reckitt Benckiser Pharmaceuticals announced May 19 that it is codeveloping what would be the first nasally administered naloxone-based therapy to treat emergency cases of opioid overdose from heroin or prescription painkillers.

Nasal spray for depression offers minimally invasive treatment option

A nasal spray could offer a new route by which to administer a peptide used to treat depression, as published in a new study by researchers at the Toronto, Canada-based Centre for Addiction and Mental Health. It's the first time this type of delivery has been used to treat the condition.

Acorda reports positive data for epilepsy nasal spray

Acorda Therapeutics posted positive results of its first clinical feasibility study of its diazepam nasal spray to treat patients with epilepsy.

Researchers reverse Parkinson's damage with nasal gene delivery

Researchers at Northeastern University have developed a treatment for Parkinson's disease meant to revive dying neurons in the brain via delivery through the nose.

Army aims to cut suicide in a sniff

An Indiana University School of Medicine team is using a $3 million, three-year grant from the U.S. Army to develop a nanoparticle nasal spray to curb suicides.

Feds back nasal med for cyanide poisoning

The Biomedical Advanced Research and Development Authority (BARDA) has awarded $4.4 million to the Southwest Research Institute (SwRI) in San Antonio to develop a nasal-delivery version of a cyanide

Nasal delivery of insulin appears to help Alzheimer's patients

Insulin, delivered in a nasal spray, seems to improve cognitive function in Alzheimer's patients, according to research appearing in the Journal of Neurology. Nasal delivery is appropriate because

New nasal delivery method may offer faster, better pain relief

Through the nose might be a better, non-invasive route to pain relief using a "pressurized olfactory device" (POD) to deliver opioid drugs, according to research outlined in the September issue of